跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
ENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled syringe
Approved
STANDARD
ENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled syringe
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f58858d31c0cf1a5
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f58858d31c0cf1a5
Product Name
ENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled syringe
Artg Id
317261
Artg Name
ENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled syringe
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2020-05-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/3fc040fac72ea9195d5b9867d35b0858.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f58858d31c0cf1a5
Type
Standard
Back to TGA Approvals